Shanghai INT Medical Instruments Co., Ltd. (INT Medical) filed its monthly return for the period ended 30 April 2026, confirming that the company’s share structure and public-float status remained unchanged during the month.

INT Medical’s issued share capital stayed at 211.20 million shares (par value: RMB1 each), split between 139.41 million H shares listed on the Hong Kong Stock Exchange and 71.79 million domestic shares. No treasury shares were outstanding.

The company affirmed compliance with the Main Board’s minimum public-float requirement, maintaining at least 25% of H shares in public hands as of 30 April 2026.

INT Medical reported no share options, warrants, convertible instruments, or other agreements that would result in additional share issuance, and there were no repurchases, cancellations, or transfers of treasury shares during the month.

Chairman and Executive Director Liang Dongke signed the filing on 6 May 2026, attesting that all regulatory obligations associated with the company’s share capital remain fully satisfied.